# Scholar Rock Holding Corporation (SRRK): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/srrk for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $41.71 USD |
| Market Cap | $5.08B |
| P/E (TTM) | — |
| EPS (TTM) | −$3.45 |
| 52-Week Range | $27.07 – $61.76 |
| Dividend Yield (TTM) | — |

## Dividend

SRRK has no dividend payment history in our records.

## Frequently Asked Questions

### What does Scholar Rock Holding Corporation do?

Scholar Rock Holding Corporation (SRRK) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is SRRK's market cap?

Scholar Rock Holding Corporation (SRRK) has a market capitalization of approximately $5.08 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does SRRK pay a dividend?

No, Scholar Rock Holding Corporation (SRRK) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is SRRK profitable?

Scholar Rock Holding Corporation (SRRK) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has SRRK ever paid a dividend?

No. Dividend Data's records show no dividend payments from Scholar Rock Holding Corporation (SRRK). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/srrk
- Dividend history & safety: https://www.dividenddata.com/stocks/srrk/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/srrk/earnings
- Financial statements: https://www.dividenddata.com/stocks/srrk/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/srrk/valuation
- Peer comparison: https://www.dividenddata.com/stocks/srrk/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.